600664.SS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 03:00):

Stats
Today's Volume	81.52M
Average Volume	33.63M
Market Cap	7.59B
EPS	CNY0 ( 2024-04-10 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	18.81
ATR14	CNY0.0100 (0.33%)

Volume Correlation

Long: 0.05 (neutral)

Short: 0.04 (neutral)

Signal:(40.097) Neutral

Harbin Pharmaceutical Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Harbin Pharmaceutical Correlation - Currency/Commodity

0.00
( neutral )

-0.43
( neutral )

0.00
( neutral )

-0.53
( weak negative )

Harbin Pharmaceutical Financials

Annual	2023
Revenue:	CNY15.34B
Gross Profit:	CNY3.77B (24.56 %)
EPS:	CNY0.160

FY	2023
Revenue:	CNY15.34B
Gross Profit:	CNY3.77B (24.56 %)
EPS:	CNY0.160

FY	2022
Revenue:	CNY13.81B
Gross Profit:	CNY3.41B (24.67 %)
EPS:	CNY0.180

FY	2021
Revenue:	CNY12.80B
Gross Profit:	CNY3.04B (23.71 %)
EPS:	CNY0.150

Financial Reports:

No articles found.

Harbin Pharmaceutical

Harbin Pharmaceutical Group Co., Ltd. engages in the research, development, manufacture, and trade of pharmaceuticals in China and internationally. The company operates through seven segments: Antibiotics, Small-Molecular Drug Preparations, OTC and Healthcare Products, Modern Chinese Medicines, Biopharmaceuticals, Animal Vaccines, and Medicine Circulations. It offers a series of penicillin and cephalosporin products, as well as intermediates. The company's lead products include Shuang Huanglian freeze-dried injection; Danshen freeze-dried injection; Shuang Huanglian powder for injection; roxithromycin dispersible tablets; belladonna, sulfamethoxazole, and trimerhoprim tablets; pediatric paracetamol, atificial cow-bezoar, and chlorphenamine maleate granules; Shuanghuanglian oral liquid; and ceftriaxone sodium for injection. Its lead products also comprise amoxicillin capsules, cefotiam hydrochloride for injection, panax ginseng extract, cefepime hydrochloride for injection, cefoperazone sodium for injection, and amoxicillin sodium and clavulanate potassium for injection; cefuroxime sodium, ceftazidime, cefotaxime sodium, and ceftriaxone sodium for injections; and ampicillin capsules. In addition, the company offers medical protective and disposable surgical masks, medical disposable protective gowns, and isolation gowns. It offers its products under the Hongyan Yaopin, Guangwei, Renmin Tongtai, Hayao Shengwu, Baohulu, Manshanhong, Hutong, Hayaoliu, Gaizhonggai, Sanchine, Shiyitang, and Hayao brands. The company is based in Harbin, China.